GUTS (Fractyl Health, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Fractyl Health, Inc. Common Stock (GUTS) is a publicly traded Healthcare sector company. As of May 21, 2026, GUTS trades at $0.91 with a market cap of $127.93M and a P/E ratio of -0.47. GUTS moved +12.56% today. Year to date, GUTS is -55.28%; over the trailing twelve months it is -56.13%. Its 52-week range spans $0.38 to $3.48. Analyst consensus is strong buy with an average price target of $5.00. Rallies surfaces GUTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns GUTS stock?
Hedge funds tracked by Rallies that own GUTS include Maverick Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fractyl Health, Inc. Common Stock.
GUTS Key Metrics
Key financial metrics for GUTS
Metric
Value
Price
$0.91
Market Cap
$127.93M
P/E Ratio
-0.47
EPS
$-1.86
Dividend Yield
0.00%
52-Week High
$3.48
52-Week Low
$0.38
Volume
4.75K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-140.95M
Gross Margin
0.00%
Top Hedge Funds Holding GUTS
Maverick Capital holds 3.97M shares of GUTS, changed -6.44% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own GUTS include Maverick Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fractyl Health, Inc. Common Stock.
Does Rallies show 13F holders for GUTS?
Yes. Rallies tracks hedge fund and 13F ownership data for GUTS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GUTS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GUTS. It does not provide personalized investment advice.
